Tolevamer, an orally administered, toxin-binding polymer for Clostridium difficile-associated diarrhea
{{output}}
Genzyme Corp is developing tolevamer, an anionic toxin-binding polymer that binds and neutralizes the Clostridium difficile A and B toxins, for the potential treatment of C difficile-associated diarrhea (CDAD). Two phase III clinical trials of tolevamer in pat... ...
